Skip to search formSkip to main contentSkip to account menu

Antistreptolysin O

Known as: aso, Streptolysin O Ab, antistreptolysin O (ASO) antibody 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Background: Mogat1 inhibition improves glucose metabolism in obese mice, but its effects on liver injury are unknown. Results… 
2014
2014
Background: Lung cancer is the lead cause of cancer-related mortality around the world. Non-small cell lung cancer (NSCLC… 
2008
2008
Human serum albumin (HSA) nanoparticles represent a promising tool for targeted drug delivery to tumor cells. The coupling of the… 
2004
2004
RationaleCompared with the use of classic receptor ligands, antisense oligonucleotides (ASO) targeted at specific central nervous… 
Highly Cited
2000
Highly Cited
2000
Cancers overexpressing Bcl-2 protein, which prevents programmed cell death (apoptosis), are less sensitive to stresses that… 
Highly Cited
1996
Highly Cited
1996
The blood of most patients with active multiple myeloma (MM) contains cells related to the bone marrow tumor. However… 
1996
1996
In acute lymphoblastic leukaemia (ALL), investigation of minimal residual disease by conventional morphology and immunology fails… 
Highly Cited
1994
Highly Cited
1994
A series of antisense oligonucleotides (ASOs) were synthesized and tested to define the best target sites within an RNA… 
Highly Cited
1992
Highly Cited
1992
Antisense oligonucleotides (ASOs) are designed to bind to a specific mRNA and selectively suppress its translation. To facilitate… 
Highly Cited
1989
Highly Cited
1989
Gaucher disease (GD), which results from mutations in the human acid beta-glucosidase (beta-Glc) gene, was used as a model system…